PUBLISHER: The Business Research Company | PRODUCT CODE: 2098722
PUBLISHER: The Business Research Company | PRODUCT CODE: 2098722
Chronic disease management platforms are digital healthcare systems developed to facilitate the ongoing monitoring, coordination, and management of long-term medical conditions such as diabetes, cardiovascular disorders, asthma, and chronic respiratory diseases. These platforms utilize integrated data, remote patient monitoring, analytical tools, and communication technologies to support proactive healthcare delivery, improve adherence to treatment plans, and assist clinical decision-making throughout the care continuum.
The primary types of chronic disease management platforms include solutions and services. Solutions refer to digital platforms or software-driven systems designed to monitor, manage, and support long-term disease care while enhancing patient engagement. These platforms are classified according to disease type, including cardiovascular diseases, diabetes, cancer, respiratory diseases, and other disease categories, with key end users consisting of healthcare providers and healthcare payers.
Tariffs are influencing the chronic disease management platforms market by increasing the cost of imported digital health infrastructure, cloud computing hardware, and connected medical devices used in remote monitoring and care coordination systems. This is slowing platform deployment and integration, particularly in emerging economies and import-reliant regions such as Asia-Pacific and Latin America where healthcare systems depend on global technology providers. Software-driven segments like remote patient monitoring solutions and healthcare analytics platforms are most affected due to reliance on cross-border data infrastructure and device ecosystems. However, tariffs are also encouraging localization of digital health platforms, development of regional cloud infrastructure, and increased investment in domestic healthcare IT ecosystems, strengthening long-term resilience in chronic care management.
The chronic disease management platforms market size has grown rapidly in recent years. It will grow from $8.33 billion in 2025 to $9.56 billion in 2026 at a compound annual growth rate (CAGR) of 14.8%. The growth in the historic period can be attributed to increasing prevalence of chronic diseases globally, growing adoption of telehealth services, growth in healthcare digital infrastructure, increasing demand for continuous patient monitoring, advancements in wearable medical device adoption.
The chronic disease management platforms market size is expected to see rapid growth in the next few years. It will grow to $16.72 billion in 2030 at a compound annual growth rate (CAGR) of 15.0%. The growth in the forecast period can be attributed to the incorporation of artificial intelligence within clinical decision support systems, the widening adoption of value-driven healthcare models, the expansion of remote patient monitoring initiatives, the rising emphasis on interoperability across healthcare data systems, and the growing uptake of personalized medicine approaches. Major trends in the forecast period include AI-enabled predictive analytics platforms for chronic disease risk assessment, IoT-based remote patient monitoring ecosystems, cloud-supported interoperable electronic health record integration systems, precision medicine-oriented personalized chronic care pathways, and blockchain-powered secure patient data exchange platforms.
The increasing prevalence of lifestyle-related diseases is expected to drive the growth of the chronic disease management platforms market going forward. Lifestyle-related diseases refer to illnesses primarily caused by unhealthy habits and behaviors such as poor diet, physical inactivity, smoking, and excessive alcohol consumption. The rising prevalence of lifestyle-related diseases is attributed to increasing sedentary behavior, as more individuals spend extended hours sitting at desks, using digital devices, and engaging in limited physical activity. Chronic disease management platforms support continuous monitoring, personalized care, medication tracking, and early risk detection to assist in managing lifestyle-related conditions such as diabetes, obesity, hypertension, and cardiovascular diseases. For instance, in June 2024, according to the National Health Service, a UK-based government department, in 2023, the NHS identified over half a million (549,000) additional individuals in England at risk of developing type 2 diabetes, bringing the total number of people with non-diabetic hyperglycemia, or pre-diabetes, registered with a GP to 3,615,330. This represents a significant increase compared to 3,065,825 in 2022, highlighting a rise of nearly 20%. Therefore, the increasing prevalence of lifestyle-related diseases is driving the growth of the chronic disease management platforms market.
Key companies operating in the chronic disease management platforms market are focusing on the development of innovative solutions, such as digital therapeutics and remote patient monitoring platforms, to improve patient engagement, enhance medication adherence, and enable real-time tracking of chronic conditions along with personalized care delivery. Digital therapeutics and remote monitoring platforms are technology-enabled healthcare solutions that integrate connected medical devices, mobile applications, cloud-based analytics, and clinical support systems to remotely monitor and manage chronic diseases, providing a more proactive and data-driven alternative to conventional in-person disease management approaches. For example, in December 2025, the U.S. Food and Drug Administration (US FDA) introduced the Total Product Life Cycle Advisory Program (TAP) Pilot, an initiative aimed at accelerating the development and commercialization of innovative medical devices and digital health technologies, including chronic disease management solutions. The program offers early-stage and strategic regulatory guidance, interactive feedback, and collaborative support to medical device developers across the entire product lifecycle. It is designed to enhance patient access to high-quality digital healthcare technologies by streamlining regulatory pathways and strengthening product safety, effectiveness, and interoperability.
In March 2026, Health Recovery Solutions LLC, a US-based healthcare technology company, acquired Rimidi Inc. for an undisclosed amount. Through this acquisition, Health Recovery Solutions aims to expand and strengthen its remote patient monitoring and chronic disease management capabilities by integrating Rimidi's EHR-connected clinical workflows, diabetes management solutions, and continuous glucose monitoring (CGM) expertise into its enterprise virtual care platform. Rimidi Inc. is a US-based healthcare technology company specializing in EHR-integrated remote patient monitoring software, chronic disease management solutions, and connected care technologies.
Major companies operating in the chronic disease management platforms market are Oracle Corporation, Koninklijke Philips N.V., Baxter International Inc., Epic Systems Corporation, Teladoc Health Inc., athenahealth Inc., Innovaccer Inc., Amwell, CareCloud Inc., Greenway Health LLC, Arcadia Solutions LLC, DarioHealth Corp., Omada Health Inc., TimeDoc Health LLC, ChartSpan Medical Technologies Inc., Vida Health Inc., HealthSnap Inc., Optimize Health Inc., CareHarmony LLC, Murphi AI Inc., Mahalo Health Inc., KangarooHealth Inc.
North America was the dominant region in the chronic disease management platforms market in 2025. Asia-Pacific is expected to be the rapidly expanding region in the forecast period. The regions covered in chronic disease management platforms report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
The countries covered in the chronic disease management platforms market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
The chronic disease management platforms market includes revenues earned by entities by providing services such as software-as-a-service (SaaS) platform subscriptions, remote patient monitoring, care coordination and workflow automation, electronic health record (EHR) integration, predictive analytics and clinical decision support, telehealth and virtual care enablement, patient engagement tools, data analytics and reporting, implementation and system integration, customization of digital care pathways, training and support services, and ongoing maintenance and upgrades. The market value includes the value of related goods and embedded digital tools sold by the service provider or included within the platform offering. Only goods and services traded between entities or provided directly to end users are included.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
The chronic disease management platforms market research report is one of a series of new reports from The Business Research Company that provides chronic disease management platforms market statistics, including chronic disease management platforms industry global market size, regional shares, competitors with a chronic disease management platforms market share, detailed chronic disease management platforms market segments, market trends and opportunities, and any further data you may need to thrive in the chronic disease management platforms industry. This chronic disease management platforms market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
Chronic Disease Management Platforms Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses chronic disease management platforms market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Where is the largest and fastest growing market for chronic disease management platforms ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The chronic disease management platforms market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.